Ann: Creso Pharma completes US OTC dual listing, page-135

Still early in the process, but looks like it's playing out how I suggested it most likely would, by balancing somewhere in between the US high and the previous ASX price. Not a bad thing though, people just need to temper expectations.
It's still early days given it listed on OTC right before a weekend so couldn't follow the opening day with any momentum, but if ASX closes today below the US closing price, I'm guessing the US price will come down to match tonight. Momentum might build later in the week.

As long as it finishes green for the day, big or small it's all positive movement